Skip to content
mainLogo
  • Home
  • About Us
  • Accelerating Clinical Trials
    • Physician-focused Trial Acceleration
    • Clinical Trial Education Workshops
    • Case Studies
  • Oncology Meeting Innovations
    • Overview
    • Industry Partnerships
    • Calendar of Events
  • One Oncology
    • Overview
    • Knowledge
    • Insights
    • Consultative Services
  • News
  • Contact

News

November 16, 2022

DAVA’s Best Practices in Multiple Myeloma (November 30th, 2022)

Posted in Best Practices

Post navigation

DAVA’s Targeted Webinar on Chronic Lymphocytic Leukemia (November 29th, 2022)
DAVA’s Best Practices in Lung Cancer (December 1st, 2022)

Recent Posts

  • DAVA’s Best Practices in Multiple Myeloma (December 20th, 2022)
  • DAVA’s Targeted Webinar on Non-Small Cell Lung Cancer (December 19th, 2022)
  • DAVA’s Targeted Webinar on Lung Caner (December 16th, 2022)
  • DAVA’s Targeted Webinar on Chronic Lymphocytic Leukemia (December 15th, 2022)
  • DAVA’s Targeted Webinar on Lung Cancer (December 15th, 2022)

Archives

  • November 2022 (16)
  • September 2019 (1)
  • July 2019 (1)
  • March 2019 (1)
  • January 2019 (1)

FOLLOW DAVA ONCOLOGY ON SOCIAL MEDIA

  • twitter
  • linkedin

Accelerating Clinical Trials

  • Physician-focused Trial Acceleration
  • Clinical Trial Education Workshops
  • Case Studies

Oncology Meeting Innovations

  • Overview
  • Industry Partnerships
  • Calendar of Events

One Oncology

  • Overview
  • Knowledge
  • Insights
  • Consultative Services
  • Subscription Access

Contact

2700 W Plano PKWY, Plano, TX 75075

PH: 214-451-4500

About

News

DAVA ONCOLOGY | © COPYRIGHT 2018 | PRIVACY POLICY

Demo Coming Soon

Relapsed/Refractory Multiple Myeloma

CAR-T

Bispecific Antibodies

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT
logo
  • Home
  • About Us
  • Accelerating Clinical Trials
    • Physician-focused Trial Acceleration
    • Clinical Trial Education Workshops
    • Case Studies
  • Oncology Meeting Innovations
    • Overview
    • Industry Partnerships
    • Calendar of Events
  • One Oncology
    • Overview
    • Knowledge
    • Insights
    • Consultative Services
  • News
  • Contact